YIDU TECH (02158) Secures Consecutive Wins on Leading Hospital Projects, Signs at CIFTIS to Jointly Build Laboratory, Accelerating Medical AI Implementation

On September 14, YIDU TECH (02158) announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., won the bid for the aging and health innovation transformation construction project of the National Clinical Research Center for Geriatric Diseases at Xiangya Hospital of Central South University, with a total project amount of approximately RMB 3.57 million. The National Clinical Research Center for Geriatric Diseases at Xiangya Hospital is a national-level scientific research platform. YIDU TECH's winning of this bid indicates that its technical capabilities in the fields of medical AI data governance and clinical research services have once again been recognized by a leading medical institution. Relative to the project amount, the benchmark significance of the collaboration platform is more prominent. This bid win is not an isolated event. Just one week earlier, YIDU TECH announced that it had won the bid for the domestic adaptation upgrade and renovation project of the data platform of Shanghai Pulmonary Hospital, also amounting to approximately RMB 3.57 million. Consecutive orders in specialty fields such as respiratory diseases and geriatric diseases, as well as in the direction of regional data platforms, show that the company's medical AI solutions are accelerating into core medical scenarios. Among them, the "domestic adaptation" direction aligns with the current policy orientation of independent and controllable medical informatization and has continuity. More noteworthy is the company's layout during the CIFTIS. On September 12, YIDU TECH signed a cooperation agreement with the Beijing Municipal Health Big Data and Policy Research Center to jointly build an "Intelligent Clinical Research Joint Laboratory." The cooperation focuses on three major directions: compliant utilization of health and medical data, drug clinical trials and medical research services, and cultivation of interdisciplinary talent. Unlike a single project cooperation, this signing means that YIDU TECH has established a collaborative relationship spanning industry, academia, research, and education with an institution affiliated with the Beijing Municipal Health Commission, extending its role from solution provider to co-builder of industry standards and infrastructure. The compliant utilization of data governance efficiency is a key bottleneck for the large-scale implementation of medical AI, and in-depth exploration in this field will help the company accumulate first-mover advantages. At the signing, company co-founder and CEO Xu Jiming said that the in-depth development of medical AI must be built on a high-quality data foundation and withstand verification through clinical and scientific research practice. Judging from recent developments, YIDU TECH's business advancement shows three characteristics: bid wins are spreading from single points to multiple points, covering scenarios such as respiratory diseases, geriatric diseases, and regional data platforms; the level of cooperation is extending from hospital departments to institutions in the health commission system, with enhanced policy synergy; and the business mainline of "data governance + clinical research + compliant utilization" is becoming clearer. Analysts believe that the pace of consecutive bid wins and deep binding with government research institutions reflect that the company's growth path is gradually being consolidated. Medical digitalization is a long-cycle track, and YIDU TECH's choice to deeply cultivate data governance and the related technology foundation will make its business base more solid, and the company's medium- to long-term fundamentals are expected to continue improving.